JBF Capital’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

JBF Capital’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-23,394	Closed	-$94.7K	–	81
2023 Q4	$94.7K	Buy	+23,394	New	+$71.4K	0.02%	72

JBF Capital's THRX Position: Q1 2024 in Review

JBF Capital sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 23,394 shares — an estimated $94.7K sold.

JBF Capital first reported a position in THRX in Q4 2023 and held it in 1 quarter. The position peaked at $94.7K in Q4 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

JBF Capital reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
JBF Capital sold 23,394 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $94.7K.
JBF Capital first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
JBF Capital's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $94.7K in Q4 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on JBF Capital's 13F filing for Q1 2024, filed 14 May 2024.